AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
RenovoRx CEO Shaun Bagai will present at the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th. He will discuss the company's commercial efforts, market traction, and clinical research, including the ongoing Phase III TIGeR-PaC clinical trial for intra-arterial gemcitabine delivered via RenovoCath in locally advanced pancreatic cancer.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet